Abstract
Summary
(1) Prostaglandins E1, E2, F1α or F2α significantly increased the release of GH, with a parallel increase in intracellular cAMP concentrations, while they only potentiated HE-stimulated TSH release.
(2) None of the prostaglandins examined consistently effected either the basal or HE-altered release of LH, FSH or prolactin.
(3) The prostaglandin synthetase inhibitor, indomethacin, inhibited GH and TSH release and, at high doses of the drug, inhibited prolactin release. In contrast, the drug appeared to potentiate both HE and sLRF-stimulated gonadotropin release. It had no significant effect on intracellular cAMP concentration.
Get full access to this article
View all access options for this article.
